Literature DB >> 21634007

Liver allocation and distribution: possible next steps.

Kenneth Washburn1, Elizabeth Pomfret, John Roberts.   

Abstract

Recent discussions about the distribution of cadaveric liver allografts for transplantation have raised many important issues. Over the past 2 years, a deliberative process including discussions, modeling, a request for information, a public forum, and a concept document has led to a greater focus on a possible path for reducing wait-list mortality. Here we describe that process, our interpretation of the feedback and responses, and possible recommendations.
Copyright © 2011 American Association for the Study of Liver Diseases.

Mesh:

Year:  2011        PMID: 21634007     DOI: 10.1002/lt.22349

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  25 in total

1.  Same policy, different impact: Center-level effects of share 35 liver allocation.

Authors:  Douglas R Murken; Allison W Peng; David D Aufhauser; Peter L Abt; David S Goldberg; Matthew H Levine
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

2.  Outcomes of Donation After Circulatory Death Liver Grafts From Donors 50 Years or Older: A Multicenter Analysis.

Authors:  Kristopher P Croome; Amit K Mathur; David D Lee; Adyr A Moss; Charles B Rosen; Julie K Heimbach; C Burcin Taner
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

3.  Multiple listings as a reflection of geographic disparity in liver transplantation.

Authors:  Parsia A Vagefi; Sandy Feng; Jennifer L Dodge; James F Markmann; John P Roberts
Journal:  J Am Coll Surg       Date:  2014-05-02       Impact factor: 6.113

4.  Geographic disparities in liver supply/demand ratio within fixed-distance and fixed-population circles.

Authors:  Christine E Haugen; Tanveen Ishaque; Abel Sapirstein; Alexander Cauneac; Dorry L Segev; Sommer Gentry
Journal:  Am J Transplant       Date:  2019-03-18       Impact factor: 8.086

5.  Barriers to transplantation in adults with inborn errors of metabolism.

Authors:  S M Sirrs; H Faghfoury; E M Yoshida; T Geberhiwot
Journal:  JIMD Rep       Date:  2012-08-22

6.  Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.

Authors:  Yan-Hua Lai; Wei-Dong Duan; Qiang Yu; Sheng Ye; Nian-Jun Xiao; Dong-Xin Zhang; Zhi-Qiang Huang; Zhan-Yu Yang; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

7.  Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points.

Authors:  Allyson Hart; David P Schladt; Jessica Zeglin; Joshua Pyke; W Ray Kim; John R Lake; John P Roberts; Ryutaro Hirose; David C Mulligan; Bertram L Kasiske; Jon J Snyder; Ajay K Israni
Journal:  Transplantation       Date:  2016-10       Impact factor: 4.939

Review 8.  Diagnostic and therapeutic management of hepatocellular carcinoma.

Authors:  Francesco Bellissimo; Marilia Rita Pinzone; Bruno Cacopardo; Giuseppe Nunnari
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 9.  Liver transplantation for hepatocellular carcinoma.

Authors:  Jerome Byam; John Renz; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2013-02       Impact factor: 7.293

Review 10.  Kidney, pancreas and liver allocation and distribution in the United States.

Authors:  J M Smith; S W Biggins; D G Haselby; W R Kim; J Wedd; K Lamb; B Thompson; D L Segev; S Gustafson; R Kandaswamy; P G Stock; A J Matas; C J Samana; E F Sleeman; D Stewart; A Harper; E Edwards; J J Snyder; B L Kasiske; A K Israni
Journal:  Am J Transplant       Date:  2012-11-16       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.